Amalgamated Financial’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$515K Buy
+13,286
New +$515K ﹤0.01% 1502